NumFin

Sorrento Therapeutics, Inc.

Sümbol: SRNE

NASDAQ

0.014

USD

Turuhind täna

  • -0.0174

    P/E suhe

  • -0.0016

    PEG suhe

  • 7.72M

    MRK Cap

  • 0.00%

    DIV tootlus

Sorrento Therapeutics, Inc. (SRNE) Finantsaruanded

Download
AastaneQuarterly
LineaarneLog
Diagrammil näete Sorrento Therapeutics, Inc. (SRNE) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist NaN M, mis on NaN % gowth. Kogu perioodi keskmine brutokasum on NaN M, mis on NaN %. Keskmine brutokasumi suhtarv on NaN %. Ettevõtte eelmise aasta tulemuse puhaskasv on NaN %, mis on võrdne NaN % % keskmiselt kogu ettevõtte ajaloo jooksul.,

AastaneQuarterly
10Y20Y30Y40Y

Bilanss

Sukeldudes Sorrento Therapeutics, Inc. fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja . Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus NaN. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud NaN aruandlusvaluutas. Selle aspekti aastane muutus on NaN%.

common:word.in-mln

USD
Growth
TTM20222021202020192018201720162015201420132012201120102009200820072006200520042003

balance-sheet.row.cash-and-short-term-investments

050126.956.5
22.5
159
20.9
83.5
136.4
71.9
31.7
5.1
3.5
5.3
3.4
0.4
0
0
0
0
0

balance-sheet.row.short-term-investments

026.390.20
0
0.3
0.4
1.1
97.4
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

024.518.715.5
14.5
4.4
3.9
3
2.6
0.7
0.4
0.1
0.1
0.2
0
0
0
0
0
0
0

balance-sheet.row.inventory

0108.11.8
3.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-current-assets

03.17.53.7
27.2
16.2
4.9
3.2
2
1.3
0.6
0.1
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-current-assets

096.417386.2
67.6
179.6
29.7
89.7
141
73.9
32.6
5.3
3.6
5.6
3.5
0.4
0
0
0
0
0

balance-sheet.row.property-plant-equipment-net

0138.4126.573.9
76.3
24.4
19.3
12.7
7.2
2.3
2.4
1.5
1
0.1
0.1
0
0
0
0
0
0

balance-sheet.row.goodwill

080.379.543.6
38.3
38.3
38.3
41.5
20.6
24
24
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

0136.9259.773.7
63.3
66.3
71
64.8
3.9
31
33.3
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

0217.2339.2117.2
101.6
104.6
109.3
106.3
24.5
55
57.4
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-investments

017.251.3256.4
262.2
265
270
189
170.1
10
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

03.74.82
49.9
50.6
3.3
3.9
0.6
0.3
0.1
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-non-current-assets

0376.5521.8449.6
490
444.5
401.9
311.9
202.5
67.6
60
1.5
1
0.1
0.1
0
0
0
0
0
0

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

0472.8694.8535.8
557.6
624.1
431.6
401.6
343.5
141.5
92.6
6.8
4.6
5.7
3.6
0.4
0
0
0
0
0

balance-sheet.row.account-payables

047.527.424.7
27.6
13.8
9.9
8.3
1.3
1.7
2.2
0.4
0.2
0.2
0.3
0
0
0.5
0
0.1
0.1

balance-sheet.row.short-term-debt

030.243.526.8
39.6
10.2
0
0.2
4.8
3.3
0.4
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-payables

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

0104.3194.1142.6
251.2
223.1
5.2
47.1
4.4
8.8
4.4
0
0
0
0
0
0
0
0
0
0

Deferred Revenue Non Current

07.1118.9113.2
114.4
116.3
119.3
134.4
110.9
1.1
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

0249.667.440.5
44.4
35
65.2
57.9
-86.2
3.5
3
0.1
0.1
0.2
0
0
0
0
0
0.2
0.2

balance-sheet.row.total-non-current-liabilities

0166.6477.2298.6
409.7
355
146
239
171.7
23.3
20.3
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

099.19553.9
55.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

0494.5616.7395.1
524.9
416.6
225
315.1
202.6
32.8
25.8
0.6
0.4
0.6
0.4
0
0
0.5
0
0.3
0.3

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

00.100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.retained-earnings

0-1959.4-1386.6-958.3
-659.8
-367.8
-165.1
-174.3
-113.3
-67.5
-32.9
-11
-6.1
-2.9
-1.1
-1.7
-1.5
-1.2
-0.8
-1.1
-1.1

balance-sheet.row.accumulated-other-comprehensive-income-loss

01.510.5
-0.3
0
0.2
-0.1
73.6
-1.7
-0.9
-0.5
-0.2
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

01939.31464.31122.9
738.7
577.2
364.4
254.4
184.9
177.9
100.6
17.6
10.5
7.9
4.2
2.1
1.5
0.7
0.7
0.7
0.7

balance-sheet.row.total-stockholders-equity

0-18.678.7165.2
78.6
209.5
199.6
80
145.2
108.7
66.8
6.2
4.2
5.1
3.2
0.4
0
-0.5
0
-0.3
-0.3

balance-sheet.row.total-liabilities-and-stockholders-equity

0472.8694.8535.8
557.6
624.1
424.6
401.6
343.5
141.5
92.6
6.8
4.6
5.7
3.6
0.4
0
0
0
0
0

balance-sheet.row.minority-interest

0-3.1-0.6-24.4
-45.8
-2
0
6.5
-4.2
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

0-21.778.1140.7
32.8
207.5
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

043.5141.5256.4
262.2
265.3
270.4
190.1
267.5
10
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-debt

0134.5237.6169.4
290.8
233.3
5.2
47.3
9.2
12.1
4.8
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-debt

0110.9200.9112.9
268.3
74.5
-15.2
-35.1
-29.8
-59.8
-26.9
-5.1
-3.5
-5.3
-3.4
-0.4
0
0
0
0
0

Rahavoogude aruanne

Sorrento Therapeutics, Inc. finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab NaN nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides NaN, mis tähistab NaN erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli NaN. See on NaN nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte NaN, NaN, NaN, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid NaN, kusjuures erinevus võrreldes eelmise aastaga oli NaN. Lisaks eraldas ettevõte NaN aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui NaN, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln

USD
Growth
TTM20222021202020192018201720162015201420132012201120102009200820072006200520042003

cash-flows.row.net-income

0-577.8-429.1-314.4
-363
-212.5
11.1
-63.9
-50.1
-34.7
-21.9
-4.8
-3.2
-1.8
-0.9
-0.2
-0.3
-0.4
0.3
0
0

cash-flows.row.depreciation-and-amortization

013.212.511
11
9.1
7.1
2.9
2.4
3.2
1.3
0.3
0.2
0
0
0
0
0
0
0
0

cash-flows.row.deferred-income-tax

0-1.8-35.9-2.1
-0.4
-6.1
-35.7
1
33.3
-1.7
0
0
3.2
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

074.890.231.4
12.6
6.2
5
4.7
7
3.9
1.8
0.9
0.3
0.3
0.1
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

069.6-2.83.8
7.2
6
-17.6
25.5
14.8
-0.2
0.4
-0.1
0
0
0.2
0
-0.5
0.4
-0.3
0
0

cash-flows.row.account-receivables

0-5.7-3-1.1
0
0
0
0
-0.2
0
0.1
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-9.58.610.2
0
0
0
0
7.8
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.account-payables

09.9-3.9-3.7
10.2
3.6
1.6
3.7
-2.7
-0.5
0.9
0
0
-0.1
0.1
0
-0.5
0
0
0
0

cash-flows.row.other-working-capital

074.9-4.6-1.7
-3
2.4
-19.2
21.8
9.9
0.3
-0.6
-0.1
0
0.1
0
0
0
0
-0.3
0
0

cash-flows.row.other-non-cash-items

0128.183.4110.8
159.5
85.6
-69
-41.1
-49.5
0.7
1.9
0
-3.2
0
0
0
0.1
0
0
0
0

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-13.7-8.9-37.6
-11.4
-11.2
-11
-6.9
-3.7
-0.6
-0.9
-0.5
-1.1
0
0
0
0
0
0
0
0

cash-flows.row.acquisitions-net

0-14.9-36-2.3
-9.7
0
-5.6
-10.6
27.8
0
0.4
0
0
0
0.1
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

0000
0
0
0
0
-11.5
-10
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.sales-maturities-of-investments

00124.80
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-investing-activites

0000
-17
-10
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.net-cash-used-for-investing-activites

0-28.579.8-39.9
-38.2
-21.2
-16.5
-17.5
12.6
-10.6
-0.5
-0.5
-1.1
0
0.1
0
0
0
0
0
0

cash-flows.row.debt-repayment

0-188.3-85.7-205.6
-3.1
-45.7
-53.2
-9.5
-3.1
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-issued

0402.3201.8317.9
47.7
83.6
57.9
108
0
71.8
37.7
5.9
2
3.4
4.1
0.6
0.7
0
0
0
0

cash-flows.row.common-stock-repurchased

000-55
0
0
0
-15.6
0
0
37701.4
5.9
0
4.2
6
0
0
0
0
0
0

cash-flows.row.dividends-paid

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

097.765.2116.9
34.3
288.1
48.9
48.8
-0.3
7.8
-37695.5
-5.9
0
-4.2
-6
0
0
0
0
0
0

cash-flows.row.net-cash-used-provided-by-financing-activities

0311.7181.3174.2
78.9
326
53.7
131.7
-3.3
79.6
43.6
6
2
3.4
4.1
0.6
0.7
0
0
0
0

cash-flows.row.effect-of-forex-changes-on-cash

0-2.40.80.9
-0.3
-0.1
0.1
0
0
0
0
0
0
0
0.7
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

0-13-19.8-24.3
-132.6
192.9
-62
43.4
-32.9
40.2
26.6
1.6
-1.8
1.8
4.1
0.4
0
0
0
0
0

cash-flows.row.cash-at-end-of-period

023.636.756.5
80.8
213.3
20.4
82.4
39
71.9
31.7
5.1
3.5
5.3
3.4
0.4
0
0
0
0
0

cash-flows.row.cash-at-beginning-of-period

036.756.580.8
213.3
20.4
82.4
39
71.9
31.7
5.1
3.5
5.3
3.4
-0.7
0
0
0
0
0
0

cash-flows.row.operating-cash-flow

0-293.9-281.8-159.5
-173
-111.8
-99.2
-70.9
-42.1
-28.8
-16.5
-3.8
-2.7
-1.5
-0.7
-0.2
-0.7
0
0
0
0

cash-flows.row.capital-expenditure

0-13.7-8.9-37.6
-11.4
-11.2
-11
-6.9
-3.7
-0.6
-0.9
-0.5
-1.1
0
0
0
0
0
0
0
0

cash-flows.row.free-cash-flow

0-307.5-290.7-197.1
-184.4
-123
-110.2
-77.8
-45.8
-29.4
-17.4
-4.3
-3.8
-1.6
-0.8
-0.2
-0.7
0
0
0
0

Kasumiaruande rida

Sorrento Therapeutics, Inc. tulud muutusid võrreldes eelmise perioodiga NaN%. SRNE brutokasum on teatatud NaN. Ettevõtte tegevuskulud on NaN, mille muutus võrreldes eelmise aastaga on NaN%. Kulud amortisatsioonikulud on NaN, mis on NaN% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on NaN, mis on NaN% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on NaN, mis tähendab NaN% kasvu võrreldes eelmise aastaga. Tegevustulu on NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on NaN%. Eelmise aasta puhaskasum oli NaN.

common:word.in-mln

USD
Growth
TTM20222021202020192018201720162015201420132012201120102009200820072006200520042003

income-statement-row.row.total-revenue

062.852.940
31.4
21.2
151.9
8.2
4.6
3.8
0.5
0.6
0.5
0.7
0
0
0
0
0
0
0

income-statement-row.row.cost-of-revenue

033.5139.9
12.2
7.1
3.9
0.8
1.9
2
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.gross-profit

029.439.930
19.2
14.1
147.9
7.3
2.6
1.8
0.5
0.6
0.5
0.7
0
0
0
0
0
0
0

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

04.34.14.1
3.9
3
2.6
0.8
1.2
2.3
0.8
0
0
0
0
0
0
0
-0.3
0
0

income-statement-row.row.operating-expenses

0407.9407.9231.6
214.4
143.6
96.5
67.2
52.6
36.3
16.1
5.4
3.8
2.5
1
0.2
0.2
0.4
-0.3
0
0

income-statement-row.row.cost-and-expenses

0441.3420.9241.5
226.6
150.7
100.4
68
54.6
38.4
16.1
5.4
3.8
2.5
1
0.2
0.2
0.4
-0.3
0
0

income-statement-row.row.interest-income

0000
1.1
0.9
0.2
0.3
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.interest-expense

08.610.220.2
36.1
57.6
5
1.6
1.7
1.6
0.3
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-183.2-94.5-109.1
-164.4
-63.4
-10
31.9
60.2
-1.6
-0.2
0
0
0
0
0
0
0
-0.3
0
0

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

04.34.14.1
3.9
3
2.6
0.8
1.2
2.3
0.8
0
0
0
0
0
0
0
-0.3
0
0

income-statement-row.row.total-operating-expenses

0-183.2-94.5-109.1
-164.4
-63.4
-10
31.9
60.2
-1.6
-0.2
0
0
0
0
0
0
0
-0.3
0
0

income-statement-row.row.interest-expense

08.610.220.2
36.1
57.6
5
1.6
1.7
1.6
0.3
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.depreciation-and-amortization

014-15.49.7
12.1
9.1
7.1
2.9
2.4
3.2
1.3
0.3
0.2
0
0
0
0
0
0
0
0

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0-378.5-368-201.5
-195.2
-150.4
25.3
-96.8
-74
-34.7
-21.7
-4.9
-3.2
-1.8
-1
-0.2
-0.2
-0.4
-0.3
0
0

income-statement-row.row.income-before-tax

0-561.7-462.5-310.6
-359.6
-213.8
15.3
-64.8
-13.8
-36.4
-21.9
-4.8
-3.2
-1.8
-0.9
0
-0.3
0
-0.6
0
0

income-statement-row.row.income-tax-expense

0-2.4-33.5-2
-0.5
-6.3
-36
-0.9
36.3
-1.7
0
0
0
0
0
0
0
0.4
-0.3
0
0

income-statement-row.row.net-income

0-559.3-429-308.6
-359.1
-203.5
9.1
-60.9
-45.8
-34.7
-21.9
-4.8
-3.2
-1.8
-0.9
-0.2
-0.3
-0.4
-0.3
0
0
Sarnased aktsiad
Sind võib huvitada ka:
MRVI
Maravai LifeSciences Holdings, Inc..
9.86 USD
NASDAQ
CMRA
Comera Life Sciences Holdings, Inc..
0.02684 USD
NASDAQ
GUBRA.CO
Gubra A/S.
338 DKK
CPH
T5O.DE
CytoTools AG.
0.406 EUR
XETRA
6826.HK
Shanghai Haohai Biological Technology Co., Ltd..
42 HKD
HKSE
PPBT
Purple Biotech Ltd..
0.67 USD
NASDAQ
SPHRF
Starpharma Holdings Limited.
0.0774 USD
PNK

Korduma kippuv küsimus

Mis on Sorrento Therapeutics, Inc. (SRNE) koguvara?

Sorrento Therapeutics, Inc. (SRNE) koguvara on 472840000.000.

Mis on ettevõtte aastane tulu?

Aastane tulu on N/A.

Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on 0.416.

Mis on ettevõtte vaba rahavoog?

Vaba rahavoog on -0.323.

Mis on ettevõtte puhaskasumimarginaal?

Puhaskasumimarginaal on -9.463.

Mis on ettevõtte kogutulu?

Kogutulu on -5.619.

Mis on Sorrento Therapeutics, Inc. (SRNE) puhaskasum (puhaskasum)?

Puhaskasum (netotulu) on -559331000.000.

Kui suur on ettevõtte koguvõlg?

Koguvõlg on 134504000.000.

Mis on tegevuskulude arv?

Tegevuskulud on 407888000.000.

Milline on ettevõtte rahaline näitaja?

Ettevõtte raha on 0.000.